Current concepts in functioning endocrine tumors of the pancreas

World Journal of Surgery

Volumn 28, Issue 12, 2004, Pages 1231-1238

  Proye, Charles A G ^a   Lokey, Jonathan S ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b GREENVILLE HOSPITAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; DUODENUM TUMOR; GENETIC ANALYSIS; HUMAN; PANCREAS TUMOR; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; STANDARDIZATION; TUMOR LOCALIZATION; BLOOD; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; GASTRINOMA; GENETICS; INSULINOMA; LIVER TUMOR; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS RESECTION; REVIEW;

DIAGNOSTIC AGENT; GASTRIN; GASTROINTESTINAL AGENT; OCTREOTIDE;

DUODENAL NEOPLASMS; ENDOSONOGRAPHY; GASTRINOMA; GASTRINS; GASTROINTESTINAL AGENTS; HUMANS; INSULINOMA; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; OCTREOTIDE; PANCREATECTOMY; PANCREATIC NEOPLASMS;

EID: 16644376148     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-004-7645-4     Document Type: Article

References (89)

1. Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann. Surg. 1955;142:709
2. Andrews A. Gut and pancreatic amine precursor uptake and decarboxylation cells are not neural crest derivatives. Gastroenterology 1983;84:429
3. Kloppel G, Heitx PU. Pancreatic endocrine tumors. Pathol. Res. Pract. 1988;183:155
4. Proye CAG. Endocrine tumors of the pancreas: an update. Aust. N. Z. Surg. 1998;68:90-100
5. Whipple AO, Frantz VK. Adenoma of the islet cell with hyperinsulinism: a review. Ann. Surg. 1935;101:1299
6. Wayne JD, Tanaka R, Kaplan EL. Insulinomas. In Clark OH, Duh Q-Y, editors, Textbook of Endocrine Surgery, Philadelphia, Saunders, 1997;579.
7. Scarlett JA, Mako ME, Rubenstein AH, et al. Factitious hypoglycemia: diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies. N. Engl. J. Med. 1977;297:1029-1032
8. Malagelada JR, Davis CS, O'Fallon WM, et al. Laboratory diagnosis of gastrinoma. Mayo Clin. Proc. 1982;57:211
9. Basso N, Passaro E. Calcium-stimulated gastric secretion in the Zollinger-Ellison syndrome. Arch. Surg. 1970;101:399
10. McGuigan JE, Wolfe MM. Secretin injection test in the diagnosis of gastrinoma. Gastroenterology 1980;79:1324
11. Frucht H, Howard JM, Slaff JI, et al. Secretin and calcium provocative test in the Zollinger-Ellison syndrome: a prospective study. Ann. Intern. Med. 1989;9:713
12. Proye CAG. Endocrine tumors of the pancreas: an update. Aust N Z Surg 1998;68:91
13. Thompson NW. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycemia or both. J. Intern. Med. 1998;243:495-500
14. MacFarlane MP, Fraker DL, Alexander R, et al. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery 1995;118:973-980
15. Benya RV, Metz DC, Venzon DJ, et al. Zollinger-Ellison syndrome can be the initial manifestation in patients with multiple endocrine neoplasia typel. Am. J. Med. 1994;97:436-444
16. Chandrasekarappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997;276:404-406
17. Bartsch D, Kopp I, Bergenfelz A, et al. MEN 1 gene mutations in 12 MEN 1 families and the associated tumors. Eur. J. Endocrinol. 1998;139:416-420
18. Doppman JL. Pancreatic endocrine tumors; the search goes on. N. Engl. J. Med. 1992;326:1770-1773
19. Bottger TC, Junginger T. Is preoperative radiographic localization of islet cell tumors in patients with insulinoma necessary? World J. Surg. 1993;17:427
20. Cougard P, Goudet P, Peix JL, et al. Les insulinomes dans les néoplasies endocriniennes multiples de type 1 (NEM1). àpropos d'une série de 44 cas du group d'étude des néoplasies endocriniennes multiples (GENEM). Ann. Chir. 2000;125:118-123
21. Chayvaille JA. A comparison of imaging techniques for the localization of gastroenteropancreatic neuroendocrine tumors. Digestion 1996;57:54-56
22. Imamura M, Takahashi K. Use of selective arterial secretin injection test to guide surgery in patients with Zollinger-Ellison syndrome. World J. Surg. 1993;17:433-438
23. Strader DB, Doppman JL, Orbuch M, et al. Functional localization of pancreatic tumors. In Mignon M, Jensen RT editors. Endocrine tumors of the pancreas. Basel. Karger, 1995;282.
24. Doppman JL, Chang R, Fraker DL, et al. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann. Intern. Med. 1995;123:269
25. Lamberts SWJ, Bakker WH, Reubi JC, et al. Somatostatin receptor imaging in the localization of endocrine tumors. N. Engl. J. Med. 1990;323:1246-1249
26. Gabril F, Reynolds JC, Doppman JL, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. Ann. Intern. Med. 1996;125:26-34
27. Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome. N. Engl. J. Med. 1999;341:635-644
28. Zimmer T, Stozel U, Bader M, et al. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localization of insulinomas and gastrinomas. Gut 1996;39:562-568
29. Proye C, Malvaux P, Pattou F, et al. Noninvasive imaging of insulinoma and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery 1998;124:1134-1144
30. Mure A, Lebtahi R, Labriolle-Vaylet C, et al. Imagerie des récepteurs de la somatostatine dans les tumeurs neuroendocrines gastroentéropancreatic. Gastroenterol. Clin. Biol. 1998;22:809-818
31. Anderson MA, Carpenter S, Thompson NW, et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am. J. Gastroenterol. 2000;95:2271-2277
32. Mirallie E, Pattou F, Malvaux P, et al. Valeurs de l'é choendoscopie et de la scintigraphie des récepteurs de la somatostatine dans la localisation pré-operatoire des insulinomes et gastrinomes. Gastroenterol. Clin. Biol. 2002;26:360-366
33. Thompson NW, Czako PF, Fritts LL, et al. Role of endoscopic ultrasonography in the localization of insulinomas and gastrinomas. Surgery 1994;116:1131-1138
34. Richards LM, Gauger PG, Thompson NW, et al. Pitfalls in the surgical treatment of insulinoma. Surgery 2002;132:1040-1049
35. Eloubeidi MA, Jhala D, Chhieng DC, et al. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer 2003;99:285-292
36. Chang KJ, Soetikno RM, Bastas D, et al. Impact of endoscopic ultrasound combined with fine-needle aspiration biopsy in the management of esophageal cancer. Endoscopy 2003;35:962-966
37. Gress FG, Barawi M, Kim D, et al. Preoperative localization of a neuroendocrine tumor of the pancreas with EUS-guided fine needle tattooing. Gastrointest. Endosc. 2002;55:594-597
38. Orlefors H, Sundin A, Fasth KJ, et al. Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo - tumor visualization using positron emission tomography with 11C-harmine. Nucl. Med. Biol. 2003;30:669-679
39. Yamauchi T, Furui S, Tsuchiya K, et al. A case of ectopic insulinoma. Rinsho Hoshasen 1988;33:1141-1142
40. Service FJ, McMahon MM, O'Brien PC, et al. Functioning insulinoma: incidence, recurrence, and long-term survival of patients: A 60 year study. Mayo Clin Proc 1991;66:711
41. Rothmund M, Angelini L, Brunt M, et al. Surgery for benign insulinoma: an international review. World J. Surg. 1990;14:393-399
42. Peix JL, Proye CAG. Stratégie et technique dans le traitement chirurgical des tumeurs endocrines duodenopancréatiques. Encycl. Méd. Chir. (Elsevier Paris), Techniques chirurgicales-Appareil digestif, 1999;40:883
43. Snajdauf J, Pycha K, Rygl M, et al. Papillary cystic and solid tumor of the pancreas-surgical therapy with the use of CUSA and a review of the pediatric literature. Eur. J. Pediatr. Surg. 1999;9:416-419
44. Boukhman MB, Karam JH, Shaver J, et al. Insulinoma - experience from 1950-1995. West. J. Med. 1998;169:90
45. Ohwada S, Ogawa T, Tanahashi Y, et al. Fibrin glue sandwich prevents pancreatic fistula following distal pancreatectomy. World J. Surg. 1998;22:494-498
46. Takao S, Shinchi H, Maemura K, et al. Ultrasonically activated scalpel is an effective tool for cutting the pancreas in biliary-pancreatic surgery: experimental and clinical studies. J. Hepatobiliary Pancreat. Surg. 2000;7:58-62
47. Sarmiento JM, Farnell MD, Que FG, et al. Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: longterm survival analysis. World J. Surg. 2002;26:1267-1271
48. Parj BJ, Alexander HR, Libutti SK, et al. Operative management of islet-cell tumors arising in the head of the pancreas. Surgery 1998;124:1056-1062
49. Vibert E, Regimbeau JM, Sauvanet A. Technique of medial pancreatectomy. Ann. Chir. 2003;128:268-272
50. Rotman N, Sastre B, Fagnier PL. Medial pancreatectomy for tumors of the neck of the pancreas. Surgery 1993;113:532-535
51. Proye CAG, Pattou F, Carnaille B, et al. Intraoperative gastrin measurements during surgical management of patients with gastrinomas: experience with 20 cases. World J. Surg. 1998;22:643-650
52. Proye CAG, Pattou F, Carnaille B, et al. Intraoperative insulin measurement during surgical management of insulinomas. World J. Surg. 1998;22:1218-1224
53. Grant CS. Insulinoma. Baillieres Clin. Gastroenterol. 1996;10:645
54. Glaser B, Shaprio B, Glowniak J. Effects of secretin on the normal and pathological β cell. J. Clin. Endocrinol. Metab. 1988;66:1138-1143
55. Imamura M, Hattori Y, Nishida O, et al. Unresponsiveness of insulinoma cells to secretin: significance of the secretin test in patients with insulinoma. Pancreas 1990;5:467-473
56. Proye CAG, Stalnikiewicz G, Wemeau JL, et al. Les insulinomes de l'adulte d'origine genetique supposée. Validation de la strategie chirugicale de l'AFCE/GENEM. Ann Endocrinol in press
57. Kaczirek K, Soleiman A, Schindl M, et al. Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism. Eur. J. Clin. Invest. 2003;33:488-492
58. Thompson NW. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J. Intern. Med. 1995;238:1
59. Thompson NW, Pasieka J, Fukuuchi A. Duodenal gastrinomas, duodenotomy and duodenal exploration in the surgical management of Zollinger-Ellison syndrome. World J. Surg. 1993;17:455-462
60. Pipeleers-Marichal M, Donow C, Heitz OV, et al. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I. World J. Surg. 1993;17:481
61. Abbound P, Bart H, Mansour G, et al. Ovarian gastrinoma in multiple endocrine neoplasia type 1: a case report. Am. J. Obstet. Gynecol. 2001;184:237-238
62. Norton JA, Alexander HR, Fraker DL, et al. Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors. Ann. Surg. 2003;237:6750-6759
63. Friesen SR. Update on the treatment of rare neuroendocrine tumors. Surg. Clin. North Am. 1987;67:2
64. Kraezlin ME, Ch'ng JC, Wood SM, et al. Long term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology 1985;88:185-187
65. Ganda OP, Weir., Soelder JS, et al. 'Somatostatinoma': a somatostatin containing tumor of the endocrine pancreas. N. Engl. J. Med. 1977;296:963-967
66. Vinik AL, Strodel WE, Eckhauser FR, et al. Somatostatinomas, VIPomas, and neurotensinomas. Semin. Oncol. 1987;14:263-281
67. Strodel WE, Vinik AL, Lloyd RV, et al. Pancreatic polypeptide producing tumors: silent lesions of the pancreas? Arch. Surg. 1984;119:508-514
68. Slim K, LeBorgne J. Ann. Chir. 2003;128:175-176
69. Gouillat C, Gigot JF. Pancreatic surgical complications-the case for prophylaxis. Gut 2001;49:32-39
70. Hofland LJ, Lanberts SW. The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocr. Rev. 2003;24:28-47
71. Culler RM. Cure of pancreatic fistula by the roentgen ray. J. A. M. A. 1920;75:20
72. Morris SJ, Barkin JS, Kalser MH, et al. Radiation therapy of a pancreatic fistula. Am. J. Gastroenterol. 1979;72:431-433
73. Papachristou DN, Fortner JG. Pancreatic fistula complicating pancreatectomy for malignant disease. Br. J. Surg. 1981;63:238-240
74. Thompson NW. Pancreatic surgery for endocrine tumors. In Clark OH, Duh Q-Y, editors, Textbook of Endocrine Surgery, Philadelphia, Saunders, 1997;599-606.
75. Norton JA, Cornelius MJ, Doppman JL, et al. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1: a prospective study. Surgery 1987;102:958-966
76. Akerstrom G, Hessman O, Skogsied B. Timing and extent of surgery in symptomatic and asymptomatic pneuroendocrine tumors of the pancreas in MEN 1. Langenbecks Arch. Surg. 2002;386:558-569
77. Delcore R, Friesen SR. Role of pancreaticoduodenectomy in the management of primary duodenal wall gastrinomas in patient with Zollinger-Ellison syndrome. Surgery 1992;112:1022-1023
78. Tisell LE, Ahlman H, Jansson S, et al. Total pancreatectomy in the MEN-1 syndrome. Br. J. Surg. 1997;75:154-157
79. Bartsch DK, Langer P, Wild A, et al. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance. Surgery 2000;128:958-966
80. Smith MC, Liu J, Chen T, et al. OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy. Digestion 2000;62:69-72
81. Moertel CG, Hamley JA, Johnson LA. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet cell carcinoma. N. Engl. J. Med. 1980;303:1198
82. Kurose T, Seino Y, Ishida H, et al. Successful treatment of metastatic glucagonoma with dacarbazine. Lancet 1984;17:621-622
83. Jeanmougin M, Civatte J, Bonvalet D, et al. Metastatic glucagonoma. Complete remission by dacarbazine. Ann. Dermatol. Venereol. 1988;115:833-838
84. Proye C. Natural history of liver metastasis of gastroenteropancreatic neuroendocrine tumors: place for chemoembolization. World J. Surg. 2001;25:685-688
85. Sarmiento JM, Que FG. Hepatic surgery for metastases from neuroendocrine tumors. Surg. Oncol. Clin. N. Am. 2003;12:231-242
86. Elias D, Lasser P, Ducreux M, et al. Liver resection (and associated extra-hepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery 2003;133:375-382
87. Olausson M, Friman S, Cahlin C, et al. Indications and results of liver transplantation in patients with neuroendocrine tumors. World J. Surg. 2002;26:998-1004
88. Olausson M, Friman S, Cahlin C, et al. Indications and results of liver transplantation in patients with neuroendocrine tumors. World J. Surg. 1996;26:998-1004
89. Dousset B, Saint-Marc O, Pitre J, et al. Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J. Surg. 1996;20:908-914